PortfoliosLab logoPortfoliosLab logo
ENVA vs. MEDP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ENVA vs. MEDP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enova International, Inc. (ENVA) and Medpace Holdings, Inc. (MEDP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ENVA achieves a 9.12% return, which is significantly higher than MEDP's -18.47% return.


ENVA

1D
1.61%
1M
-1.92%
YTD
9.12%
6M
26.22%
1Y
77.69%
3Y*
49.36%
5Y*
36.19%
10Y*
36.71%

MEDP

1D
0.80%
1M
8.00%
YTD
-18.47%
6M
-16.62%
1Y
54.44%
3Y*
30.12%
5Y*
21.82%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ENVA vs. MEDP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ENVA
Enova International, Inc.
9.12%63.95%73.19%44.28%-6.32%65.36%2.95%23.64%28.03%21.12%
MEDP
Medpace Holdings, Inc.
-18.47%69.05%8.38%44.31%-2.40%56.35%65.60%58.81%45.97%0.53%

Correlation

The correlation between ENVA and MEDP is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.29

Correlation (3Y)
Calculated over the trailing 3-year period

0.32

Correlation (5Y)
Calculated over the trailing 5-year period

0.35

Correlation (All Time)
Calculated using the full available price history since Aug 12, 2016

0.32

Fundamentals

Market Cap

ENVA:

$4.52B

MEDP:

$13.26B

EPS

ENVA:

$12.29

MEDP:

$15.63

PE Ratio

ENVA:

13.95

MEDP:

29.29

PEG Ratio

ENVA:

0.76

MEDP:

0.88

PS Ratio

ENVA:

1.39

MEDP:

5.04

PB Ratio

ENVA:

3.22

MEDP:

22.17

Total Revenue (TTM)

ENVA:

$3.28B

MEDP:

$2.68B

Gross Profit (TTM)

ENVA:

$1.23B

MEDP:

$778.59M

EBITDA (TTM)

ENVA:

$456.13M

MEDP:

$572.96M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ENVA vs. MEDP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ENVA
ENVA Risk / Return Rank: 8686
Overall Rank
ENVA Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
ENVA Sortino Ratio Rank: 8686
Sortino Ratio Rank
ENVA Omega Ratio Rank: 8484
Omega Ratio Rank
ENVA Calmar Ratio Rank: 8585
Calmar Ratio Rank
ENVA Martin Ratio Rank: 8585
Martin Ratio Rank

MEDP
MEDP Risk / Return Rank: 7373
Overall Rank
MEDP Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
MEDP Sortino Ratio Rank: 7373
Sortino Ratio Rank
MEDP Omega Ratio Rank: 8282
Omega Ratio Rank
MEDP Calmar Ratio Rank: 7070
Calmar Ratio Rank
MEDP Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ENVA vs. MEDP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enova International, Inc. (ENVA) and Medpace Holdings, Inc. (MEDP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ENVAMEDPDifference
Sharpe ratioReturn per unit of total volatility

+1.26

Sortino ratioReturn per unit of downside risk

+0.84

Omega ratioGain probability vs. loss probability

1.34

1.32

+0.02

Calmar ratioReturn relative to maximum drawdown

3.16

1.49

+1.66

Martin ratioReturn relative to average drawdown

8.14

3.38

+4.76

ENVA vs. MEDP - Sharpe Ratio Comparison

The current ENVA Sharpe Ratio is 2.06, which is higher than the MEDP Sharpe Ratio of 0.79. The chart below compares the historical Sharpe Ratios of ENVA and MEDP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ENVAMEDPDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.06

0.79

+1.26

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.90

0.43

+0.48

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.75

Sharpe Ratio (All Time)

Calculated using the full available price history

0.34

0.67

-0.33

Drawdowns

ENVA vs. MEDP - Drawdown Comparison

The maximum ENVA drawdown since its inception was -81.56%, which is greater than MEDP's maximum drawdown of -42.87%. Use the drawdown chart below to compare losses from any high point for ENVA and MEDP.


Loading charts...

Drawdown Indicators


ENVAMEDPDifference

Max Drawdown

Largest peak-to-trough decline

-81.56%

-42.87%

-38.69%

Max Drawdown (1Y)

Largest decline over 1 year

-24.75%

-36.61%

+11.86%

Max Drawdown (3Y)

Largest decline over 3 years

-37.01%

-39.38%

+2.37%

Max Drawdown (5Y)

Largest decline over 5 years

-42.84%

-42.87%

+0.03%

Max Drawdown (10Y)

Largest decline over 10 years

-77.57%

Current Drawdown

Current decline from peak

-1.92%

-26.22%

+24.30%

Average Drawdown

Average peak-to-trough decline

-29.60%

-12.91%

-16.69%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.57%

16.16%

-6.59%

Volatility

ENVA vs. MEDP - Volatility Comparison

Enova International, Inc. (ENVA) has a higher volatility of 10.45% compared to Medpace Holdings, Inc. (MEDP) at 6.61%. This indicates that ENVA's price experiences larger fluctuations and is considered to be riskier than MEDP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ENVAMEDPDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.45%

6.61%

+3.84%

Volatility (6M)

Calculated over the trailing 6-month period

28.16%

37.78%

-9.62%

Volatility (1Y)

Calculated over the trailing 1-year period

38.08%

69.11%

-31.03%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

40.29%

51.61%

-11.32%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.22%

49.80%

-0.58%

Dividends

ENVA vs. MEDP - Dividend Comparison

Neither ENVA nor MEDP has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ENVA vs. MEDP - Financials Comparison

This section allows you to compare key financial metrics between Enova International, Inc. and Medpace Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


300.00M400.00M500.00M600.00M700.00M800.00M900.00M20222023202420252026
875.14M
706.60M
(ENVA) Total Revenue
(MEDP) Total Revenue
Values in USD except per share items

ENVA vs. MEDP - Profitability Comparison

The chart below illustrates the profitability comparison between Enova International, Inc. and Medpace Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%202220232024202520260
27.8%
Portfolio components
ENVA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Enova International, Inc. reported a gross profit of 0.00 and revenue of 875.14M. Therefore, the gross margin over that period was 0.0%.

MEDP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a gross profit of 196.33M and revenue of 706.60M. Therefore, the gross margin over that period was 27.8%.

ENVA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Enova International, Inc. reported an operating income of 207.11M and revenue of 875.14M, resulting in an operating margin of 23.7%.

MEDP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported an operating income of 141.50M and revenue of 706.60M, resulting in an operating margin of 20.0%.

ENVA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Enova International, Inc. reported a net income of 91.10M and revenue of 875.14M, resulting in a net margin of 10.4%.

MEDP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a net income of 123.87M and revenue of 706.60M, resulting in a net margin of 17.5%.


Frequently Asked Questions


ENVA and MEDP have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ENVA has higher volatility (10.45%) compared to MEDP (6.61%). In terms of maximum drawdown, ENVA dropped -81.56% vs MEDP's -42.87%.

ENVA currently has the higher Sharpe Ratio (2.06 vs 0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ENVA and MEDP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer